hydroxychloroquine has been researched along with Pterygium in 1 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Pterygium: An abnormal triangular fold of membrane in the interpalpebral fissure, extending from the conjunctiva to the cornea, being immovably united to the cornea at its apex, firmly attached to the sclera throughout its middle portion, and merged with the conjunctiva at its base. (Dorland, 27th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hydroxychloroquine has been applied as one of the COVID-19 treatment strategies." | 5.72 | Hydroxychloroquine treatment on SARS-CoV-2 receptor ACE2, TMPRSS2 and NRP1 expression in human primary pterygium and conjunctival cells. ( Chen, SL; Jhanji, V; Liang, JJ; Ma, D; Ng, TK; Xu, Y; Yao, Y; Yuan, XL, 2022) |
| "Hydroxychloroquine has been applied as one of the COVID-19 treatment strategies." | 1.72 | Hydroxychloroquine treatment on SARS-CoV-2 receptor ACE2, TMPRSS2 and NRP1 expression in human primary pterygium and conjunctival cells. ( Chen, SL; Jhanji, V; Liang, JJ; Ma, D; Ng, TK; Xu, Y; Yao, Y; Yuan, XL, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yao, Y | 1 |
| Ma, D | 1 |
| Xu, Y | 1 |
| Yuan, XL | 1 |
| Liang, JJ | 1 |
| Chen, SL | 1 |
| Jhanji, V | 1 |
| Ng, TK | 1 |
1 other study available for hydroxychloroquine and Pterygium
| Article | Year |
|---|---|
Hydroxychloroquine treatment on SARS-CoV-2 receptor ACE2, TMPRSS2 and NRP1 expression in human primary pterygium and conjunctival cells.
Topics: Angiotensin-Converting Enzyme 2; Biomarkers; Comorbidity; Conjunctiva; COVID-19; COVID-19 Drug Treat | 2022 |